Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:39 AM
Ignite Modification Date:
2025-12-25 @ 2:39 AM
NCT ID:
NCT02298634
Eligibility Criteria:
INCLUSION CRITERIA
* Informed consent will be obtained from the parents before any study related procedures.
* Patients of both gender older than 2 months
* The patient has a diagnosis of Farber disease or a high-grade suspicion for Farber disease
* High-grade suspicion present, if one or more inclusion criteria are valid:
1. \- Positive family anamnesis for Farber disease
2. \- Hoarse cry due to laryngeal involvement
3. \- Dysostosis multiplex
4. \- Painful swollen joints,
5. \- Arthritis
6. \- Hepatomegaly
7. \- Splenomegaly
8. \- Elevated urine ceramide levels
9. \- Histiocytic infiltration of liver, spleen, and lungs
10. \- Ceramidase deficiency
EXCLUSION CRITERIA
* No Informed consent from the parents before any study related procedures.
* Patients of both gender younger than 2 months
* No diagnosis of Farber disease or no valid criteria for profound suspicion of Farber disease
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
2 Months
Study:
NCT02298634
Study Brief:
Protocol Section:
NCT02298634